1998
DOI: 10.1073/pnas.95.22.13097
|View full text |Cite
|
Sign up to set email alerts
|

A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity

Abstract: Werner syndrome (WS) is an autosomal recessive disorder characterized by genomic instability and the premature onset of a number of age-related diseases. The gene responsible for WS encodes a member of the RecQ-like subfamily of DNA helicases. Here we show that its murine homologue maps to murine chromosome 8 in a region syntenic with the human WRN gene. We have deleted a segment of this gene and created Wrn-deficient embryonic stem (ES) cells and WS mice. While displaying reduced embryonic survival, live-born… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
194
3
1

Year Published

1999
1999
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 277 publications
(204 citation statements)
references
References 44 publications
5
194
3
1
Order By: Relevance
“…A hypersensitivity of WS cell to CPT has already been reported with the use of several end points (Lebel and Leder, 1998;Poot et al, 1999;Pichierri et al, 2000) and a higher induction of apoptosis has been previously obtained by Poot et al (1999). We confirm the higher induction of apoptosis by CPT in WS cells also after a short pulse treatment.…”
Section: Hypersensitivity Of Ws Cells To Cpt and Husupporting
confidence: 88%
See 2 more Smart Citations
“…A hypersensitivity of WS cell to CPT has already been reported with the use of several end points (Lebel and Leder, 1998;Poot et al, 1999;Pichierri et al, 2000) and a higher induction of apoptosis has been previously obtained by Poot et al (1999). We confirm the higher induction of apoptosis by CPT in WS cells also after a short pulse treatment.…”
Section: Hypersensitivity Of Ws Cells To Cpt and Husupporting
confidence: 88%
“…The observed sensitivity of WS cells to 4-nitroquinoline-1-oxide (Gebhart et al, 1988;Ogburn et al, 1997) has prompted a search for sensitivity toward drugs that interfere with DNA replication and transcription. More recently, the finding that WS cells show sensitivity to camptothecin, an agent that produces replication-dependent DNA damage, reinforces the hypothesis that WRN functions mainly during the DNA replication processes (Lebel and Leder, 1998;Poot et al, 1999;Pichierri et al, 2000). For these reasons, it has been proposed that the primary defect of this disorder is "unprotected synthesis," that is, the failure of cells to protect the integrity of the genoma during the DNA replication process (Chakraverty and Hickson, 1999).…”
Section: Introductionmentioning
confidence: 82%
See 1 more Smart Citation
“…Mice lacking part of the helicase domain of the Wrn gene were generated by homologous recombination, as described previously (11). In the process, 121 amino acid residues of the Wrn protein were deleted (aa 710 to 831).…”
Section: Animal Modelmentioning
confidence: 99%
“…Cataracts, senility and increased incidence of tumors are characteristics of aging not observed in either HGPS patients or the progeric mutant mice for reasons that are not apparent. Attempts at making a mouse model for typical Werner's syndrome have been unsuccessful, despite a 70% sequence homology between the human and mouse genes [25,26]. However the murine Wrn protein is diffusely distributed throughout the nucleus, whereas human WRN protein is primarily restricted to the nucleolus [27] (see Figure 1).…”
Section: Lamins and Diseasementioning
confidence: 99%